Please ensure Javascript is enabled for purposes of website accessibility
Jim Halley

Jim Halley


Recent articles


Why Shares of OrganiGram Popped Today

Shares in the Canadian cannabis company rose more than 4%


2 Small Cannabis Companies Showing Huge Gains

MariMed and Gage Growth are smaller cannabis companies that are posting big revenue gains. Investors looking for growth might want to get in on these two stocks before they're discovered.


3 Cannabis Stocks to Buy and Hold for the Next 10 Years

These three stocks have established themselves as consistent revenue growers. Are they good long-term choices for investors?


Why Shares of Endo Pharamecuticals Are Soaring Today

The possibility of a settlement in an opioid lawsuit the company is fighting in Tennessee raised investors' hopes.


Why FedEx Stock Has Risen More Than 13% in 2021

The company showed that it was more than a pandemic stock with a strong 2021 fiscal year.


Why Cerevel Therapeutics Is Up More Than 29% in the First Half of 2021

A positive early stage trial for a schizophrenia drug has pushed this biotech's stock this year.


Why Hexo Stock Has Climbed 14% So Far in 2021

It was an up-and-down first half for the Canadian cannabis company.

dividend investors

If You Like Dividends, You Should Love These 3 Stocks

These three companies present strong opportunities for growth -- with a nice dividend to boot.


Why Carnival Cruise Lines Stock Is Dropping Again Thursday

It's been a bad week for all cruise lines, but Carnival, in particular, has seen its shares drop.

two people review documents in front of a laptop at a kitchen counter.

3 Stocks I'd Avoid at All Costs

On the surface, these companies seem like underpriced investments, but look a little closer and there's a good reason to stay away.


Why Cassava Sciences Stock Moved Higher Monday

The biotech stock bounced back big Monday after tumbling on Friday.


Why Shares of Ocugen Are Dropping Today

Investors may be getting concerned about how long it may take for COVID-19 vaccine Covaxin to get approved.


Do Big Dividend Increases Make These 3 Medical Stocks Worth Buying?

UnitedHealth Group, Ryman Healthcare, and Dentsply Sirona all had double-digit revenue increases recently. Are any of them worth buying?


Why Workhorse Group Dropped Again Wednesday

The EV truck maker fell 9% on Wednesday and is down more than 24% over the past five days.


Why Is Everyone Talking About Nano-X Stock?

The company's breakthrough multisource X-ray imaging device has investors excited.


Why Pulse Biosciences Stock Moved Higher Thursday

The medical technology company got rid of $41.6 million in debt with a large private sale of stock on Thursday.


Why Global Blood Therapeutics Moved Higher Wednesday

The pharmaceutical company, which specializes in therapies to fight sickle cell disease, rose nearly 8% on Wednesday.

pharma1162678257 (1)

Is This Chinese Biopharma Stock Still a Buy?

The pharmaceutical company had a solid first quarter and boasts a nice pipeline.

biotech lab

3 Top Biotech Stocks to Buy Right Now

These three biotech stocks recently had positive news coming out of phase 2 trials, making them good choices for growth-oriented investors.


Is bluebird bio's Surge a Bellwether for Gene Editing Stocks?

With safety concerns allayed, the company is ready to restart clinical trials of key therapies.